The US Food and Drug Administration (FDA) has approved updated labeling for Keytruda (pembrolizumab; Merck) and Tecentriq (atezolizumab; Genentech) for patients with locally advanced or metastatic urothelial cancer who are not eligible for cisplatin-containing chemotherapy.
The USFDA is continuing to review Merck's Keytruda and Roche's Tecentriq in pr...
French biotech Abivax’s might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.
The company has announced results from the first group of patients in its most recent phase 2a trial testing the potential HIV cure treatment codenamed ABX464.
The study aimed at acc...
Regenerative therapy is a cell-based technique using stem cells to boost tissue regeneration. Though many different stem cells are used, one of the most promising is fat-derived adipose stem cells.
When tissue is damaged your body will regenerate it by replacing damaged cells through cell growth and division. Your DNA determines how your body knows when and where to regenerate. Similar to...
Proton pump inhibitors (PPIs), which include well-known brand names Prilosec, Miracid, Nexium and Prevacid, are among the most commonly prescribed medications in the world. Approximately 10 percent of adults in the United States take these drugs for frequent heartburn, acid reflux and gastroesophageal reflux disease. Given their prevalence, researchers at Skaggs School of Pharmacy and Pharmaceutic...